Christine Piette1, Gérard Durand1, Jean-François Bretagne2, Jean Faivre3. 1. ADECI35, Rennes, France. 2. Gastroenterology Unit, CHU, Rennes, France. 3. INSERM, UMR866, Dijon, France; Université Bourgogne Franche-Comté, Dijon, France; CHU Dijon Bourgogne, Dijon, France. Electronic address: jean.faivre@u-bourgogne.fr.
Abstract
BACKGROUND: Compliance with colorectal cancer screening is critical to its effectiveness. The organisation of the mass screening programme in France has recently been modified with no evaluation of the consequences. AIMS: To evaluate the impact of the way the screening test is delivered on compliance. PATIENTS AND METHODS: During the first six months of the screening campaign (Ille-Vilaine, Brittany), general practitioners were asked to propose a faecal immunochemical test (FIT), OC-Sensor, to individuals at average risk for colorectal cancer (n=152,097). A subset of non-participants in the medical phase (n=13,071) was randomly chosen to receive a reminder that included the screening test or a simple postal reminder without the screening test. RESULTS: Compliance was 31% if the screening test was proposed during a medical consultation. In non-participants during the medical phase, it was 45% in those receiving both a reminder and the screening test and 28% amongst those receiving a simple reminder. An estimated overall participation rate of 54% can be expected if non-participants in the medical phase are sent a reminder together with the screening test. CONCLUSION: In France, a compliance rate above the minimum uptake rate of 45% recommended by European Union experts can be achieved if the FIT is mailed to non-participants after the medical free-offer phase.
BACKGROUND: Compliance with colorectal cancer screening is critical to its effectiveness. The organisation of the mass screening programme in France has recently been modified with no evaluation of the consequences. AIMS: To evaluate the impact of the way the screening test is delivered on compliance. PATIENTS AND METHODS: During the first six months of the screening campaign (Ille-Vilaine, Brittany), general practitioners were asked to propose a faecal immunochemical test (FIT), OC-Sensor, to individuals at average risk for colorectal cancer (n=152,097). A subset of non-participants in the medical phase (n=13,071) was randomly chosen to receive a reminder that included the screening test or a simple postal reminder without the screening test. RESULTS: Compliance was 31% if the screening test was proposed during a medical consultation. In non-participants during the medical phase, it was 45% in those receiving both a reminder and the screening test and 28% amongst those receiving a simple reminder. An estimated overall participation rate of 54% can be expected if non-participants in the medical phase are sent a reminder together with the screening test. CONCLUSION: In France, a compliance rate above the minimum uptake rate of 45% recommended by European Union experts can be achieved if the FIT is mailed to non-participants after the medical free-offer phase.
Authors: Elisabeth F P Peterse; Caroline B Osoro; Marc Bardou; Iris Lansdorp-Vogelaar Journal: Aliment Pharmacol Ther Date: 2021-03-08 Impact factor: 8.171
Authors: Esther Toes-Zoutendijk; Isabel Portillo; Sarah Hoeck; Isabel de Brabander; Philippe Perrin; Catherine Dubois; Monique van Leerdam; Iris Lansdorp-Vogelaar; Marc Bardou Journal: J Med Screen Date: 2019-10-23 Impact factor: 2.136